Cover Image
市場調查報告書

生醫材料的全球市場 - 至2020年的預測:材料的各種類 (金屬、陶瓷、聚合物、天然生醫材料)、應用 (心血管、整形外科、牙科、整形外科、傷口護理、神經學、組織工程、眼科)

Biomaterials Market by Type of Material (Metallic, Ceramic, Polymers, Natural Biomaterials) & Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Tissue Engineering, Ophthalmology) - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 265105
出版日期 內容資訊 英文 258 Pages
訂單完成後即時交付
價格
Back to Top
生醫材料的全球市場 - 至2020年的預測:材料的各種類 (金屬、陶瓷、聚合物、天然生醫材料)、應用 (心血管、整形外科、牙科、整形外科、傷口護理、神經學、組織工程、眼科) Biomaterials Market by Type of Material (Metallic, Ceramic, Polymers, Natural Biomaterials) & Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Tissue Engineering, Ophthalmology) - Global Forecast to 2020
出版日期: 2015年12月09日 內容資訊: 英文 258 Pages
簡介

生醫材革新了預防、治療的醫療保健幾個方面,日益用於新的醫療設備、藥物遞輸系統、置換技術、人工器官、組織修復、診斷技術的開發中。對生醫材料的高需求,消費,重要性,全世界的醫學協會,經歷激進的模式轉移。

本報告提供全球生醫材料市場相關調查分析、市場概要、產業趨勢、各市場區隔的市場分析、競爭情形、主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 全球生醫材料市場概要
  • 全球生醫材料市場:各類型
  • 生醫材料市場各地區分析
  • 金屬生醫材料市場:各類型
  • 生醫材料市場各地區概述

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 機會
    • 重大的問題

第6章 全球生醫材料市場:材料的各類型

  • 簡介
  • 金屬生醫材料
  • 陶瓷
  • 聚合物
  • 天然生醫材料

第7章 生醫材料市場:各應用

  • 簡介
  • 心血管
  • 整形外科
  • 眼科
  • 牙科
  • 整形外科 (美容整形)
  • 傷口護理
  • 組織工程 (播放醫療)
  • 神經學的/中樞神經系統
  • 其他

第8章 全球生醫材料市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第9章 競爭情形

  • 競爭情形與趨勢

第10章 企業簡介 (概要、財務、產品與服務、策略與發展)

  • ROYAL DSM
  • BASF SE
  • BAYER AG
  • INVIBIO LTD. (VICTREX PLC的子公司)
  • WRIGHT MEDICAL TECHNOLOGY, INC.
  • CARPENTER TECHNOLOGY CORPORATION
  • CORBION N.V.
  • COVALON TECHNOLOGIES LTD.
  • EVONIK INDUSTRIES AG
  • ZIMMER BIOMET HOLDINGS, INC. (ZIMMER HOLDINGS, INC.的子公司)
  • BERKELEY ADVANCED BIOMATERAILS, INC.
  • CAM BIOCERAMICS BV
  • COLLAGEN MATRIX, INC.

第11章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 1556

A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems.

Biomaterials are revolutionizing several facets of preventive and therapeutic healthcare and are being increasingly used in the development of new medical devices, drug delivery systems, replacement technologies, prostheses, tissue repair, and diagnostic techniques. The medical fraternity across the globe has witnessed a radical paradigm shift due to the growing demand, consumption, and prominence of these materials. Biomaterials are the focus of major research efforts across the globe due to the quality-of-life benefits they offer. Incessant research globally for fulfilling the requirement of highly biocompatible products is a pivotal factor that is stimulating the growth of the global biomaterial market. This has led to immense development of metal, ceramic, polymer, and natural biomaterial-based products.

In 2015, the metallic segment is expected to account for the larger share of the global biomaterials market, by type of material, while the cardiovascular segment is expected to account for the largest share of biomaterial market, by application.

In 2015, North America is expected to account for the largest share of the global biomaterials market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America's large share is attributed to biomaterials-based research in the U.S., growing demand for plastic surgeries in the U.S., conferences on biomaterials in the U.S., increase in cancer incidences in the U.S., growing prevalence of cardiovascular diseases in the U.S., and increasing funding and R&D activities for biomaterials in Canada. In the coming years, the biomaterial market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. The high growth in India and China can be attributed rising cosmetic and plastic surgeries in India, lucrative medical device industry and new tax policy in China, growing number of cardiovascular diseases and increasing aging population in China, and biomaterials workshops & conferences in China.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographic expansion, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the biomaterials market. The report analyzes the biomaterials market, by type of material and by application
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the biomaterials market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various biomaterials across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the biomaterials market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the biomaterials market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key insights from primary sources
      • 2.2.2.3. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE SCENARIO
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. OVERVIEW OF THE GLOBAL BIOMATERIALS MARKET
  • 4.2. GLOBAL BIOMATERIALS MARKET, BY TYPE
  • 4.3. GEOGRAPHIC ANALYSIS OF THE BIOMATERIALS MARKET
  • 4.4. METALLIC BIOMATERIALS MARKET, BY TYPE
  • 4.5. GEOGRAPHIC SNAPSHOT OF THE BIOMATERIALS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. BIOMATERIALS MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increased funds and grants by government bodies worldwide
      • 5.3.1.2. Growing implantable devices market
      • 5.3.1.3. High growth anticipated for plastic surgery and wound healing applications
      • 5.3.1.4. Research and funding for developing novel biomaterials to boost market for cardiovascular applications
      • 5.3.1.5. Technological advancements
      • 5.3.1.6. Rising number of hip and knee replacement procedures worldwide
      • 5.3.1.7. High growth in the geriatric population coupled with growing incidence of cardiovascular diseases
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Limitations of biomaterial-based products
      • 5.3.2.2. Stringent clinical & regulatory processes
      • 5.3.2.3. Unfavorable healthcare reforms in the U.S.
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Growing healthcare market in emerging economies
      • 5.3.3.2. Increasing number of free-trade agreements
    • 5.3.4. BURNING ISSUES
      • 5.3.4.1. Biomaterials Access Assurance Act

6. GLOBAL BIOMATERIALS MARKET, BY TYPE OF MATERIAL

  • 6.1. INTRODUCTION
  • 6.2. METALLIC BIOMATERIALS
    • 6.2.1. STAINLESS STEEL
    • 6.2.2. TITANIUM & TITANIUM ALLOYS
    • 6.2.3. COBALT-CHROME ALLOYS
    • 6.2.4. GOLD
    • 6.2.5. SILVER
  • 6.3. CERAMICS
    • 6.3.1. CALCIUM PHOSPHATE
    • 6.3.2. ZIRCONIA
    • 6.3.3. ALUMINUM OXIDE
    • 6.3.4. CALCIUM SULFATE
    • 6.3.5. CARBON
    • 6.3.6. GLASS
  • 6.4. POLYMERS
    • 6.4.1. POLYMETHYLMETHACRYLATE (PMMA)
    • 6.4.2. POLYETHYLENE
    • 6.4.3. POLYESTER
    • 6.4.4. POLYVINYLCHLORIDE (PVC)
    • 6.4.5. SILICONE RUBBER
    • 6.4.6. NYLON
    • 6.4.7. POLYETHERETHERKETONE (PEEK)
  • 6.5. NATURAL BIOMATERIALS
    • 6.5.1. HYALURONIC ACID
    • 6.5.2. COLLAGEN & GELATIN
    • 6.5.3. FIBRIN
    • 6.5.4. CELLULOSE
    • 6.5.5. CHITIN
    • 6.5.6. ALGINATES
    • 6.5.7. SILK

7. BIOMATERIALS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. CARDIOVASCULAR
    • 7.2.1. STENTS
    • 7.2.2. PACEMAKERS
    • 7.2.3. IMPLANTABLE CARDIAC DEFIBLILLATORS
    • 7.2.4. HEART VALVES
    • 7.2.5. CATHETERS
    • 7.2.6. VASCULAR GRAFTS
    • 7.2.7. GUIDEWIRES
    • 7.2.8. SENSORS
    • 7.2.9. OTHERS
  • 7.3. ORTHOPEDIC
    • 7.3.1. JOINT REPLACEMENT
      • 7.3.1.1. Knee Replacement (Arthroplasty)
      • 7.3.1.2. Hip Replacement (Arthroplasty)
      • 7.3.1.3. Shoulder Replacement (Arthroplasty)
      • 7.3.1.4. Others
    • 7.3.2. VISCOSUPPLEMENTATION
      • 7.3.2.1. Knee Osteoarthritis
      • 7.3.2.2. Abdominal and Pelvic Surgeries
    • 7.3.3. BIORESORBABLE TISSUE FIXATION PRODUCTS
      • 7.3.3.1. Suture Anchors
      • 7.3.3.2. Interference Screws
      • 7.3.3.3. Meniscal Repair Tacks
      • 7.3.3.4. Meshes
    • 7.3.4. SPINE
      • 7.3.4.1. Spinal Fusion
      • 7.3.4.2. Minimally Invasive Fusion Surgeries
      • 7.3.4.3. Motion Preservation& Dynamic Stabilization
        • 7.3.4.3.1. Pedicle-based Rod Systems
        • 7.3.4.3.2. Interspinous Spacers
        • 7.3.4.3.3. Disc Arthroplasty/Replacement
      • 7.3.4.4. DEMINERALIZED BONE MATRIX
    • 7.3.5. ORTHOBIOLOGICS
      • 7.3.5.1. Autografts
      • 7.3.5.2. Allograft
      • 7.3.5.3. Synthetics
      • 7.3.5.4. Bone Morphogenetic Proteins (BMPs)
      • 7.3.5.5. Growth Factors
      • 7.3.5.6. Stem Cell Therapy
  • 7.4. OPHTHALMOLOGY
    • 7.4.1. CONTACT LENSES
    • 7.4.2. INTRAOCULAR LENSES
    • 7.4.3. FUNCTIONAL REPLACEMENTS OF OCULAR TISSUES
    • 7.4.4. SYNTHETIC CORNEAS
    • 7.4.5. OTHERS
  • 7.5. DENTAL
    • 7.5.1. DENTAL IMPLANTS
    • 7.5.2. DENTAL BONE GRAFTS & SUBSTITUTES
    • 7.5.3. DENTAL MEMBRANES
    • 7.5.4. TISSUE REGENERATION
  • 7.6. PLASTIC SURGERY
    • 7.6.1. ACELLULAR DERMAL MATRICES
    • 7.6.2. SOFT TISSUE FILLERS
    • 7.6.3. FACIAL WRINKLE TREATMENTS
    • 7.6.4. BIOENGINEERED SKIN
    • 7.6.5. CRANIOFACIAL SURGERY
    • 7.6.6. PERIPHERAL NERVE REPAIR
  • 7.7. WOUND HEALING
    • 7.7.1. FRACTURE FIXATION DEVICES
      • 7.7.1.1. Sutures
      • 7.7.1.2. Staples
      • 7.7.1.3. Bone Plates
      • 7.7.1.4. Screws
      • 7.7.1.5. Pins
      • 7.7.1.6. Rods
      • 7.7.1.7. Wires
    • 7.7.2. SKIN SUBSTITUTES
    • 7.7.3. SURGICAL HEMOSTATS
    • 7.7.4. INTERNAL TISSUE SEALANTS
    • 7.7.5. ADHESION BARRIERS
  • 7.8. TISSUE ENGINEERING
    • 7.8.1. SCAFFOLDS FOR REGENERATIVE MEDICINE
    • 7.8.2. NANOMATERIALS FOR BIOSENSING
    • 7.8.3. SELF-ASSEMBLED BIOMIMETIC COPOLYMERS
    • 7.8.4. CELL-MATERIAL INTERFACE ENGINEERING
    • 7.8.5. TAILORING OF INORGANIC NANOPARTICLES
  • 7.9. NEUROLOGICAL/CENTRAL NERVOUS SYSTEM
    • 7.9.1. SHUNTING SYSTEMS
    • 7.9.2. CORTICAL NEURAL PROSTHETICS
    • 7.9.3. HYDROGEL SCAFFOLDS FOR CNS REPAIR
    • 7.9.4. NEURAL STEM CELL ENCAPSULATION
  • 7.10. OTHER APPLICATIONS
    • 7.10.1. DRUG DELIVERY SYSTEMS
    • 7.10.2. GASTROINTESTINAL APPLICATIONS
    • 7.10.3. BARIATRIC SURGERY
    • 7.10.4. URINARY APPLICATIONS

8. GLOBAL BIOMATERIALS MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. U.S.
      • 8.2.1.1. Biomaterials-based research to drive the U.S. biomaterials market
      • 8.2.1.2. Growing demand for plastic surgeries in the U.S.
      • 8.2.1.3. Conferences on biomaterials in the U.S.
      • 8.2.1.4. Increase in cancer incidences
      • 8.2.1.5. Growing number of cardiovascular diseases to bolster growth
    • 8.2.2. CANADA
      • 8.2.2.1. Increasing R&D activities for biomaterials in Canada
  • 8.3. EUROPE
    • 8.3.1. GERMANY
      • 8.3.1.1. Rising cases of hip and knee replacements
      • 8.3.1.2. Growing medical devices industry in Germany
    • 8.3.2. U.K.
      • 8.3.2.1. Increased funds, and grants by government bodies & universities
      • 8.3.2.2. Rise in CVD prevalence in the U.K.
      • 8.3.2.3. Conferences & annual meetings
      • 8.3.2.4. Rising cosmetic surgery in the U.K. to trigger market growth
    • 8.3.3. FRANCE
      • 8.3.3.1. Favorable government support and growing aging population
    • 8.3.4. REST OF EUROPE (ROE)
      • 8.3.4.1. Improving Healthcare Structure in Russia
      • 8.3.4.2. Increasing research activities on biomaterials in Spain
      • 8.3.4.3. Spain & Poland: rising incidence of cardiovascular disease, growth in the medical tourism industry, and aging population
  • 8.4. ASIA-PACIFIC
    • 8.4.1. INTERNATIONAL ALLIANCES TO BOOST THE BIOMATERIALS MARKET
    • 8.4.2. JAPAN
      • 8.4.2.1. Japan's growing healthcare industry
    • 8.4.3. CHINA
      • 8.4.3.1. Lucrative medical devices industry in China
      • 8.4.3.2. New, favorable tax policy
      • 8.4.3.3. Growing aging population
    • 8.4.4. INDIA
      • 8.4.4.1. India, a hotspot for cosmetic and plastic surgery
      • 8.4.4.2. Increasing geriatric population in India
    • 8.4.5. REST OF ASIA-PACIFIC (ROAPAC)
      • 8.4.5.1. Rising cases of hip and knee replacement procedures in Australia
      • 8.4.5.2. Regulations limiting the growth of the biomaterials market in Indonesia
      • 8.4.5.3. Increasing research activities in Australia, Singapore, and Hong Kong
  • 8.5. REST OF THE WORLD (ROW)
      • 8.5.1.1. Increasing aging population and the subsequent rise in age-related disorders in the Middle East
      • 8.5.1.2. Rising obesity in Latin America
      • 8.5.1.3. Opportunities in the healthcare system in Brazil
      • 8.5.1.4. Increasing aging population coupled with increasing cases of cardiovascular diseases in Brazil
      • 8.5.1.5. Market scenario in Latin America and South Africa

9. COMPETITIVE LANDSCAPE

  • 9.1. COMPETITIVE SITUATION AND TRENDS
    • 9.1.1. ACQUISITIONS
    • 9.1.2. AGREEMENTS, ALLIANCES, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS
    • 9.1.3. NEW PRODUCT LAUNCHES
    • 9.1.4. EXPANSIONS
    • 9.1.5. OTHER DEVELOPMENTS

10. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 10.1. ROYAL DSM
  • 10.2. BASF SE
  • 10.3. BAYER AG
  • 10.4. INVIBIO LTD. (SUBSIDIARY OF VICTREX PLC)
  • 10.5. WRIGHT MEDICAL TECHNOLOGY, INC.
  • 10.6. CARPENTER TECHNOLOGY CORPORATION
  • 10.7. CORBION N.V.
  • 10.8. COVALON TECHNOLOGIES LTD.
  • 10.9. EVONIK INDUSTRIES AG
  • 10.10. ZIMMER BIOMET HOLDINGS, INC. (A SUBSIDIARY OF ZIMMER HOLDINGS, INC.)
  • 10.11. BERKELEY ADVANCED BIOMATERAILS, INC.
  • 10.12. CAM BIOCERAMICS BV
  • 10.13. COLLAGEN MATRIX, INC.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. DISCUSSION GUIDE
  • 11.2. COMPANY DEVELOPMENTS (2012-2015)
    • 11.2.1. ROYAL DSM
    • 11.2.2. WRIGHT MEDICAL TECHNOLOGY, INC.
    • 11.2.3. EVONIK INDUSTRIES AG
  • 11.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.4. AVAILABLE CUSTOMIZATIONS
  • 11.5. RELATED REPORT

LIST OF TABLES

  • TABLE 1: INCREASED FUNDS AND GRANTS BY GOVERNMENT BODIES WORLDWIDE IS PROPELLING THE GROWTH OF THIS MARKET
  • TABLE 2: LIMITATIONS OF BIOMATERIALS-BASED PRODUCTS RESTRAIN MARKET GROWTH
  • TABLE 3: COLOSSAL POOL OF CARDIAC PATIENTS IN INDIA TO OFFER HUGE GROWTH OPPORTUNITIES FOR THE MARKET
  • TABLE 4: GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2013-2020 (USD BILLION)
  • TABLE 5: GLOBAL METALLIC BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 6: GLOBAL METALLIC BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 7: GLOBAL STAINLESS STEEL BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: GLOBAL TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: GLOBAL COBALT-CHROME ALLOY BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: GLOBAL GOLD BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: GLOBAL SILVER BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: GLOBAL CERAMIC BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 13: GLOBAL CERAMIC BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 14: GLOBAL CALCIUM PHOSPHATE BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: GLOBAL ZIRCONIA BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: GLOBAL ALUMINUM OXIDE BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 17: GLOBAL CALCIUM SULFATE BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: GLOBAL CARBON BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: GLOBAL GLASS BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: GLOBAL POLYMERIC BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 21: GLOBAL POLYMERIC BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 22: GLOBAL POLYMETHYLMETHACRYLATE BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: GLOBAL POLYETHYLENE BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: GLOBAL POLYESTER BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: GLOBAL POLYVINYLCHLORIDE BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: GLOBAL SILICONE RUBBER BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: GLOBAL NYLON BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: GLOBAL POLYETHERETHERKETONE BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: APPLICATIONS OF NATURAL BIOMATERIALS
  • TABLE 30: GLOBAL NATURAL BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 31: GLOBAL NATURAL BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 32: GLOBAL HYALURONIC ACID BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: GLOBAL COLLAGEN & GELATIN BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: GLOBAL FIBRIN BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: GLOBAL CELLULOSE BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: GLOBAL CHITIN BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 37: GLOBAL ALGINATE BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 38: GLOBAL SILK BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 39: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD BILLION)
  • TABLE 40: BIOMATERIALS MARKET SIZE FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2013-2020 (USD BILLION)
  • TABLE 41: BIOMATERIALS MARKET SIZE FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 42: BIOMATERIALS MARKET SIZE FOR STENTS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 43: BIOMATERIALS MARKET SIZE FOR PACEMAKERS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 44: BIOMATERIALS MARKET SIZE FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 45: BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS
  • TABLE 46: BIOMATERIALS MARKET SIZE FOR HEART VALVES, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 47: BIOMATERIALS MARKET SIZE FOR CATHETERS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 48: BIOMATERIALS MARKET SIZE FOR VASCULAR GRAFTS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 49: BIOMATERIALS MARKET SIZE FOR GUIDEWIRES, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 50: BIOMATERIALS MARKET SIZE FOR SENSORS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 51: OTHER CARDIOVASCULAR BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 52: BIOMATERIALS MARKET SIZE FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 53: BIOMATERIALS MARKET SIZE FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 54: JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 55: JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 56: KNEE REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 57: HIP REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 58: SHOULDER REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 59: OTHER JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 60: VISCOSUPPLEMENTATION BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD BILLION)
  • TABLE 61: VISCOSUPPLEMENTATION BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 62: KNEE OSTEOARTHRITIS BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 63: ABDOMINAL AND PELVIC SURGERIES BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 64: BIORESORBABLE BIOMATERIALS MARKET SIZE, BY PRODUCT, 2013-2020 (USD BILLION)
  • TABLE 65: BIORESORBABLE BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 66: BIOMATERIALS MARKET SIZE FOR SUTURE ANCHORS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 67: BIOMATERIALS MARKET SIZE FOR INTERFERENCE SCREWS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 68: BIOMATERIALS MARKET SIZE FOR MENISCAL REPAIR TACKS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 69: BIOMATERIALS MARKET SIZE FOR MESHES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 70: SPINE BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD BILLION)
  • TABLE 71: SPINE BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 72: SPINAL FUSION BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 73: BIOMATERIALS MARKET SIZE FOR MINIMALLY INVASIVE FUSION SURGERIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 74: BIOMATERIALS MARKET SIZE FOR MOTION PRESERVATION & DYNAMIC STABILIZATION, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 75: BIOMATERIALS MARKET SIZE FOR MOTION PRESERVATION & DYNAMIC STABILIZATION, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 76: BIOMATERIALS MARKET SIZE FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 77: BIOMATERIALS MARKET SIZE FOR INTERSPINOUS SPACERS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 78: BIOMATERIALS MARKET SIZE FOR DISC ARTHROPLASTY/REPLACEMENT, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 79: BIOMATERIALS MARKET SIZE FOR DEMINERALIZED BONE MATRIX, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 80: BIOMATERIALS MARKET SIZE FOR ORTHOBIOLOGICS, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 81: ORTHOBIOLOGIC BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 82: AUTOGRAFT BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 83: ALLOGRAFT BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 84: SYNTHETIC BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 85: BONE MORPHOGENETIC PROTEIN BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 86: GROWTH FACTORS BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 87: STEM CELL THERAPY BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 88: BIOMATERIALS MARKET SIZE FOR OPHTHALMOLOGY APPLICATIONS, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 89: OPHTHALMOLOGY BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 90: BIOMATERIALS MARKET SIZE FOR CONTACT LENSES, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 91: BIOMATERIALS MARKET SIZE FOR INTRAOCULAR LENSES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 92: BIOMATERIALS MARKET SIZE FOR FUNCTIONAL REPLACEMENTS OF OCULAR TISSUES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 93: BIOMATERIALS MARKET SIZE FOR SYNTHETIC CORNEAS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 94: BIOMATERIALS MARKET SIZE FOR OTHER OPHTHALMOLOGY APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 95: BIOMATERIALS MARKET SIZE FOR DENTAL APPLICATIONS, BY PRODUCT, 2013-2020 (USD BILLION)
  • TABLE 96: DENTAL BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 97: BIOMATERIALS MARKET SIZE FOR DENTAL IMPLANTS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 98: BIOMATERIALS MARKET SIZE FOR DENTAL BONE GRAFTS & GRAFT SUBSTITUTES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 99: BIOMATERIALS MARKET SIZE FOR DENTAL MEMBRANES, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 100: BIOMATERIALS MARKET SIZE FOR TISSUE REGENERATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 101: BIOMATERIALS MARKET SIZE FOR PLASTIC SURGERY, BY APPLICATION, 2013-2020 (USD BILLION)
  • TABLE 102: BIOMATERIALS MARKET SIZE FOR PLASTIC SURGERY, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 103: BIOMATERIALS MARKET SIZE FOR ACELLULAR DERMAL MATRICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 104: BIOMATERIALS MARKET SIZE FOR SOFT TISSUE FILLERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 105: BIOMATERIALS MARKET SIZE FOR FACIAL WRINKLE TREATMENTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 106: BIOMATERIALS MARKET SIZE FOR BIOENGINEERED SKIN, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 107: BIOMATERIALS MARKET SIZE FOR CRANIOFACIAL SURGERY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 108: BIOMATERIALS MARKET SIZE FOR PERIPHERAL NERVE REPAIR, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 109: BIOMATERIALS MARKET SIZE FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2013-2020 (USD BILLION)
  • TABLE 110: BIOMATERIALS MARKET SIZE FOR WOUND HEALING APPLICATIONS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 111: BIOMATERIALS MARKET SIZE FOR FRACTURE FIXATION DEVICES, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 112: BIOMATERIALS MARKET SIZE FOR FRACTURE FIXATION DEVICES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 113: BIOMATERIALS MARKET SIZE FOR SUTURES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 114: BIOMATERIALS MARKET SIZE FOR STAPLES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 115: BIOMATERIALS MARKET SIZE FOR BONE PLATES, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 116: BIOMATERIALS MARKET SIZE FOR SCREW, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 117: BIOMATERIALS MARKET SIZE FOR PINS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 118: BIOMATERIALS MARKET SIZE FOR RODS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 119: BIOMATERIALS MARKET SIZE FOR WIRES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 120: BIOMATERIALS MARKET SIZE FOR SKIN SUBSTITUTES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 121: BIOMATERIALS MARKET SIZE FOR SURGICAL HEMOSTATS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 122: BIOMATERIALS MARKET SIZE FOR INTERNAL TISSUE SEALANTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 123: BIOMATERIALS MARKET SIZE FOR ADHESION BARRIERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 124: TISSUE ENGINEERING BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD BILLION)
  • TABLE 125: TISSUE ENGINEERING BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 126: TISSUE ENGINEERING BIOMATERIALS MARKET SIZE FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 127: TISSUE ENGINEERING BIOMATERIALS MARKET SIZE FOR NANOMATERIALS FOR BIOSENSING, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 128: TISSUE ENGINEERING BIOMATERIALS MARKET SIZE FOR SELF-ASSEMBLED BIOMIMETIC COPOLYMERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 129: TISSUE ENGINEERING BIOMATERIALS MARKET SIZE FOR CELL-MATERIAL INTERFACE ENGINEERING, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 130: TISSUE ENGINEERING BIOMATERIALS MARKET SIZE FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 131: BIOMATERIALS MARKET SIZE FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 132: BIOMATERIALS MARKET SIZE FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 133: BIOMATERIALS MARKET SIZE FOR SHUNTING SYSTEMS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 134: BIOMATERIALS MARKET SIZE FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 135: BIOMATERIALS MARKET SIZE FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 136: BIOMATERIALS MARKET SIZE FOR NEURAL STEM CELL ENCAPSULATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 137: OTHER BIOMATERIAL APPLICATIONS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 138: OTHER BIOMATERIAL APPLICATIONS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 139: BIOMATERIALS MARKET SIZE FOR DRUG DELIVERY SYSTEMS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 140: BIOMATERIALS MARKET SIZE FOR GASTROINTESTINAL APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 141: BIOMATERIALS MARKET SIZE FOR BARIATRIC SURGERY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 142: BIOMATERIALS MARKET SIZE FOR URINARY APPLICATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 143: BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 144: NORTH AMERICA: BIOMATERIALS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 145: NORTH AMERICA: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 146: NORTH AMERICA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD BILLION)
  • TABLE 147: U.S.: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 148: U.S.: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD BILLION)
  • TABLE 149: CANADA: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 150: CANADA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 151: EUROPE: BIOMATERIALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
  • TABLE 152: EUROPE: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 153: EUROPE: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD BILLION)
  • TABLE 154: GERMANY: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 155: GERMANY: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 156: U.K.: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 157: U.K.: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 158: FRANCE: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 159: FRANCE: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 160: REST OF EUROPE (ROE): BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 161: REST OF EUROPE (ROE): BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 162: ASIA-PACIFIC: BIOMATERIALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
  • TABLE 163: ASIA-PACIFIC: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 164: ASIA-PACIFIC: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD BILLION)
  • TABLE 165: JAPAN: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 166: JAPAN: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 167: CHINA: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 168: INDIA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 169: INDIA: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 170: INDIA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 171: ROAPAC: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 172: INDIA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 173: ROW: BIOMATERIALS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 174: ROW: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 175: ACQUISITIONS, 2012-2015
  • TABLE 176: AGREEMENTS, ALLIANCES, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS, 2012-2015
  • TABLE 177: NEW PRODUCT LAUNCHES, 2012-2015
  • TABLE 178: EXPANSIONS, 2012-2015
  • TABLE 179: OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL BIOMATERIALS MARKET SEGMENTATION
  • FIGURE 2: GLOBAL BIOMATERIALS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: POLYMERIC BIOMATERIALS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 8: TITANIUM & TITANIUM ALLOYS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 9: TITANIUM & TITANIUM ALLOYS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 10: POLYMETHYLMETHACRYLATE (PMMA) SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 11: HYALURONIC ACID SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 12: PLASTIC SURGERY SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 13: ASIA-PACIFIC REGION TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 14: ATTRACTIVE OPPORTUNITIES IN THE BIOMATERIALS MARKET
  • FIGURE 15: PLASTIC SURGERY SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: NORTH AMERICA TO DOMINATE THE BIOMATERIALS MARKET, BY TYPE
  • FIGURE 17: TITANIUM & TITANIUM ALLOYS SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 18: ASIA-PACIFIC TO WITNESS HIGHEST GROWTH RATE FROM 2015 TO 2020
  • FIGURE 19: GLOBAL BIOMATERIALS MARKET, BY TYPE OF MATERIAL
  • FIGURE 20: POLYMERIC BIOMATERIALS TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 21: ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 22: GLOBAL METALLIC BIOMATERIALS MARKET, BY TYPE
  • FIGURE 23: TITANIUM AND TITANIUM ALLOYS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 24: GLOBAL CERAMIC BIOMATERIALS MARKET, BY TYPE
  • FIGURE 25: CALCIUM PHOSPHATE SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 26: GLOBAL POLYMERS BIOMATERIAL MARKET, BY TYPE
  • FIGURE 27: PMMA SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 28: GLOBAL NATURAL BIOMATERIALS MARKET, BY TYPE
  • FIGURE 29: HYALURONIC ACID SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 30: BIOMATERIALS MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 31: PLASTIC SURGERY SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 32: CARDIOVASCULAR BIOMATERIALS MARKET SEGMENTATION
  • FIGURE 33: STENTS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 34: ORTHOPEDIC BIOMATERIALS MARKET SEGMENTATION
  • FIGURE 35: OPHTHALMOLOGY BIOMATERIALS MARKET SEGMENTATION
  • FIGURE 36: INTRAOCULAR LENSES SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 37: DENTAL BIOMATERIALS MARKET SEGMENTATION
  • FIGURE 38: DENTAL IMPLANTS SEGMENT EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 39: PLASTIC SURGERY BIOMATERIALS MARKET SEGMENTATION
  • FIGURE 40: ACELLULAR DERMAL MATRICES SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 41: WOUND HEALING BIOMATERIALS MARKET SEGMENTATION
  • FIGURE 42: FRACTURE FIXATION DEVICES SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 43: TISSUE ENGINEERING BIOMATERIALS MARKET SEGMENTATION
  • FIGURE 44: SCAFFOLDS FOR REGENERATIVE MEDICINE SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 45: NEUROLOGICAL/CENTRAL NERVOUS SYSTEM BIOMATERIALS MARKET SEGMENTATION
  • FIGURE 46: CORTICAL NEURAL PROSTHETICS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 47: OTHER BIOMATERIAL APPLICATIONS
  • FIGURE 48: DRUG DELIVERY SYSTEMS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 49: NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE GLOBAL BIOMATERIALS MARKET IN 2015
  • FIGURE 50: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 51: EUROPE: MARKET SNAPSHOT
  • FIGURE 52: ASIA-PACIFIC: MARKET SNAPSHOT
  • FIGURE 53: ROW: MARKET SNAPSHOT
  • FIGURE 54: BATTLE FOR MARKET SHARE: ACQUISITIONS WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS (2012-2015)
  • FIGURE 55: ROYAL DSM: COMPANY SNAPSHOT
  • FIGURE 56: BASF SE: COMPANY SNAPSHOT
  • FIGURE 57: BAYER AG: COMPANY SNAPSHOT
  • FIGURE 58: VICTREX PLC: COMPANY SNAPSHOT
  • FIGURE 59: WRIGHT MEDICAL TECHNOLOGY, INC.: COMPANY SNAPSHOT
  • FIGURE 60: CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT
  • FIGURE 61: CORBION N.V.: COMPANY SNAPSHOT
  • FIGURE 62: COVALON TECHNOLOGIES LTD.: COMPANY SNAPSHOT
  • FIGURE 63: EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
  • FIGURE 64: ZIMMER HOLDINGS, INC.: COMPANY SNAPSHOT
Back to Top